asset acquisition
Bruker Acquires German Biomolecular Interactions Firm Dynamic Biosensors
The acquisition will bolster Bruker's biophysical portfolio for the analysis of molecular interactions and kinetics in drug discovery research.
Danaher Acquires Swiss Informatics Firm Genedata
The acquisition will add to Danaher's tools for drug discovery, development, and manufacturing and follows several previous collaborations between the two companies.
Thermo Fisher Completes $3.1B Acquisition of Olink
With the deal, the life science firm adds Olink's high-plex immunoassay Explore HT platform to its mass spectrometry-based proteomics offerings.
Fluidic Sciences Acquires Assets of Fluidic Analytics, Relaunches Protein Research Tool
The firm is relaunching the Fluidity One-M instrument originally developed by now defunct Fluidic Analytics, targeting biopharma research customers.
Bruker Q1 Revenues Rise 5 Percent, Missing Analysts' Estimate
The firm has closed its acquisition of diagnostics firm EliTechGroup for €870 million ($929.3 million) in cash, excluding the carved-out EliTech clinical chemistry business.